logo

NHI

National Health·NYSE
--
--(--)
--
--(--)
8.95 / 10
Outperform

NHI's fundamental profile is strong, highlighted by a high operating cycle efficiency (230.78 days, Group 1) and an impressive fixed assets turnover ratio (7979.42, Group 2). While net profit margin is negative (-2972.64%), indicating operational inefficiencies, other ratios such as shareholders' equity growth (8.37%, Group 4) and quick ratio (2.20, Group 1) remain favorable. The weighted score of 8.95/10 and positive performance metrics across most factors underscore a solid balance sheet and asset utilization, contributing to an Outperform fundamental stance.

Fundamental(8.95)SentimentTechnical

Analysis Checks(5/10)

Operating cycle
Value230.78
Score2/3
Weight335.06%
1M Return1.33%
Non-current assets / Total assets (%)
Value55.36
Score1/3
Weight-118.86%
1M Return-0.48%
Quick ratio
Value2.20
Score2/3
Weight68.91%
1M Return0.27%
Non-current liabilities / Total liabilities (%)
Value53.32
Score1/3
Weight-58.29%
1M Return-0.23%
Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)
Value8.37
Score1/3
Weight261.61%
1M Return0.96%
Net profit margin (%)
Value-2972.64
Score2/3
Weight-120.32%
1M Return-0.49%
Fixed assets turnover ratio
Value7979.42
Score2/3
Weight-117.61%
1M Return-0.48%
Cost of sales ratio (%)
Value70.53
Score2/3
Weight84.09%
1M Return0.33%
Current assets / Total assets (%)
Value45.05
Score1/3
Weight-118.48%
1M Return-0.48%
Current ratio
Value9.92
Score1/3
Weight-116.11%
1M Return-0.47%
Is NHI undervalued or overvalued?
  • NHI scores 8.95/10 on fundamentals and holds a Discounted valuation at present. Backed by its 7.20% ROE, 41.00% net margin, 27.14 P/E ratio, 2.66 P/B ratio, and 9.25% earnings growth, these metrics solidify its Outperform investment rating.